chateau lake louise - etouches · pdf filejune 6-8, 2014 chateau lake louise lake louise,...
TRANSCRIPT
J U N E 6 - 8 , 2 0 1 4C H A T E A U L A K E L O U I S EL A K E L O U I S E , A L B E R T A
C O N F E R E N C E P R O G R A M
Steering CommitteeChair: Dr. Tara Chalmers-Nixon, University of CalgaryDr. Robert Bailey, Royal Alexandra Hospital, University of AlbertaDr. Kelly Burak, University of CalgaryDr. Shane Devlin, University of CalgaryDr. Richard Fedorak, University of Alberta
Program CommitteeChair: Dr. Shane Devlin, University of CalgaryDr. Kelly Burak, University of CalgaryDr. Steve Heitman, University of CalgaryDr. Karen Kroeker, University of AlbertaDr. Sarah Robbins, University of AlbertaDr. Clarence Wong, University of Alberta
Endoscopy Program CommitteeChair: Dr. Tara Chalmers-Nixon, University of CalgaryDr. Steven Heitman, University of CalgaryDr. Naseem Hoque, University of AlbertaDr. Jonathan Love, University of CalgaryDr. Rachid Mohamed, University of CalgaryDr. Gurpal Sandha, University of AlbertaDr. Rick Sultanian, University of AlbertaDr. Sergio Zepeda-Gomez, University of Alberta
Nurses Program CommitteeChair: Dr. Kelly Burak, University of CalgaryMs. Sharon Appelman-Eszczuk, University of AlbertaMs. Kim Kostiuk, University of AlbertaMs. Clare McCabe-Woodrow, University of AlbertaMs. Daphne Meyer, Royal Alexandra HospitalMs. Joni Tsougrianis, University of CalgaryMs. Connie Wescott, Peter Lougheed Centre
Accreditation:
This event is an Accredited Group Learning Activity(Section 1) as defined by the Maintenance ofCertification program of The Royal College of Physiciansand Surgeons of Canada, and approved by the Universityof Calgary Office of Continuing Medical Education andProfessional Development. Participants can claim up toa maximum of 18 hours study credits.
ADDS Program 2014.qxp_Layout 1 2014-05-28 11:43 AM Page B
1
LEARNING OBJECTIVES:l Communicate state-of-the-art knowledge in the
diagnosis and treatment of liver disease,inflammatory bowel disease and othergastrointestinal issues
l Articulate the key findings of current research intothe treatment of celiac disease, pancreatitis andviral hepatitis
l Discuss the latest developments in the treatmentand diagnosis of colorectal cancer
l Continue to build the network of basic and clinicalinvestigators in order to promote translational andclinical research relating to gastrointestinal disease
l Learn how to better educate patients about therisks and benefits, as well as treatment andmanagement options, for common GI diseases
S C H E D U L E A T A G L A N C E
Friday, June 6, 2014
Pre-Conference Sessions
7:00 am – 7:00 pm Registration Open Alpine Gallery
7:00 – 8:00 am Breakfast Symposium Lakeshore / Beehive Targeted vs. Systemic: Delivering Patient Outcomes
8:30 – 11:30 am CONCURRENT SESSIONS:
GI/Liver Nurses’ Program – Part 1 Lakeshore / Beehive
Shaffer Awards – Part 1 Mount Temple A
11:30 am – 1:00 pm Lunch Lago Restaurant
Posters Alpine Gallery
11:45 am – 12:45 pm Lunch Symposium: Mount Temple AManaging the Treatment-Experienced Hepatitis C Patient in a New Era
11:45 am – 12:45 pm Lunch Symposium: Mount Temple B/CExploring the Early Phase of Crohn’s Disease
1:00 – 4:00 pm CONCURRENT SESSIONS:
GI/Liver Nurses’ Program – Part 2 Lakeshore / Beehive
Shaffer Awards – Part 2 Mount Temple A
Advanced Therapeutic Mount Temple B/CEndoscopy in Alberta
Alberta Digestive Disease Summit
4:30 – 4:45 pm Opening Remarks Mount Temple B/C
4:45 – 6:45 pm PLENARY SESSION #1: State-of-the-Art Updates Mount Temple B/C
6:45 – 7:30 pm Reception Victoria Foyer
7:30 – 10:00 pm Alberta Society of Gastroenterology Night VictoriaDinner, Shaffer Awards Ceremony and Alberta Society of Gastroenterology Awards
2
Saturday, June 7, 2014
7:00 am – 1:00 pm Registration Open Alpine Gallery
7:00 – 8:00 am Breakfast Symposium: Mount Temple ACancer in IBD: #PracticeChangingInformation
7:00 – 8:00 am Breakfast Symposium: Mount Temple B/CIBD and Therapeutic Drug Monitoring
8:15 – 10:15 am PLENARY SESSION #2: Mount Temple B/CColorectal Cancer Updates
10:15 – 10:30 am Break
10:30 am – 12:30 pm PLENARY SESSION #3: Mount Temple B/CState-of-the-Art Updates
12:30 – 1:30 pm Family Lunch Lago Restaurant
Free Afternoon
1:30 – 4:30 pm Fellows’ Exam Prep Course Lakeshore / Beehive
6:30 – 11:30 pm Family BBQ and Dance Brewster Barn
Sunday, June 8, 2014
7:00 am – 1:00 pm Registration Open Alpine Gallery
7:00 – 8:00 am Breakfast Symposium: Mount Temple ACurrent Management of HCV: The Path to IFN Freedom
7:00 – 8:00 am Breakfast Symposium: Mount Temple B/CSubsequent Entry Biologics in IBD:Past, Present and Future Clinical Considerations
8:15 – 10:15 am CONCURRENT SESSIONS:Landmark Liver Updates Mount Temple ALandmark Luminal Updates Mount Temple B/C
10:15 – 10:30 am Break
10:30 am – 12:30 pm PLENARY SESSION #4: Mount Temple B/CUpdates in Therapeutics
12:30 – 2:00 pm Family Lunch Lago Restaurant
12:30 – 2:00 pm Alberta Society of Gastroenterology Mount Temple AAnnual General Meeting + Luncheon
3
Friday, June 6, 2014
Preconference Sessions
7:00 – 8:00 am Breakfast Symposium: Lakeshore / Beehive Targeted vs. Systemic: Delivering Patient Outcomes
This Symposium was made possible by an unrestrictededucational grant from Takeda Canada
Learning Objectives:
l Provide an overview of the clinical implications of targetedbiologic treatment in IBD
l Discuss the safety profile of targeted and systemic biologictreatments in IBD
l Provide an opportunity to dialogue with the experts on optimalpatient management
Chair: Dr. Remo Panaccione, Inflammatory Bowel DiseaseClinic, University of Calgary
Shaping the Future of IBD: Unmet Needs and Biologic TherapiesDr. Shane Devlin, Division of Gastroenterology, University of Calgary
Safety of IBD Treatments: Does the Mechanism of Disease Matter?Prof. Laurent Peyrin-Biroulet, International Organization for the Study of Inflammatory Bowel Disease, Nancy University Hospital
8:30 – 11:30 am CONCURRENT SESSIONS
8:30 – 11:30 am GI / Liver Nurses’ Program – Part 1 Lakeshore / Beehive
8:30 – 8:35 am Welcome & Opening RemarksDr. Kelly Burak, Division of Gastroenterology, University of Calgary
4
D E T A I L E D P R O G R A M
8:35 – 9:00 am Blending Research and Clinical CareDr. Richard Fedorak, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Describe how clinical care integrates into clinical research.l Discuss the process of moving a patient from clinical care into
clinical researchl Explain the role Alberta clinical research has played in the
development of medications for clinical care.
9:00 – 9:15 am Blending Research and Clinical CareMs. Sharon Appelman-Eszczuk, GILDR Group,Division of Gastroenterology, University of Alberta
9:15 – 9:25 am Q&A
9:25 –10:10 am Waiting too Long to See a Gastroenterologist? ImprovingAccess to Gastroenterology Through Central Access andTriage: A Nurse-Navigator Program for Dyspepsia and IBSDr. Kerri Novak, Division of Gastroenterology,University of Calgary
Ms. Colleen Johnston, Calgary Foothills Hospital
Learning Objectives:
l Describe the merits of a centralized model for processingreferrals, known as Central Access Triage (CAT)
l Outline a state of the art approach to both dyspepsia andirritable bowel syndrome
l Understand the role of the nurse educator in a novel, nurse-based stream for common, functional GI conditions such asdyspepsia and irritable bowel syndrome
10:10 – 10:20 am Q&A
10:20 – 10:35 am Break
10:35 – 11:00 am Capsule EndoscopyMs. Kathleen Wasyliw, Royal Alexandra Hospital
Learning Objectives:
l Describe the method and purpose of video capsule endoscopyl Discuss the role of nurse/doctor for video capsule endoscopyl Review case studies for video capsule endoscopy
5
11:00 – 11:20 am Nurse-Led EndoscopyMs. Melissa Harriott, University of Alberta Hospital
Learning Objectives:
l Explain the history and future of nurse led endoscopyl Learn the training requirements of an independent nurse
endoscopist l Recognize the potential impact of nurse led endoscopy on CRC
screening l Common challenges and pitfalls to nurse performed endoscopy
11:20 – 11:30 am Q&A
8:30 – 11:30 am Shaffer Awards - Part 1 Mount Temple A
8:30 – 8:45 pm Welcome & Opening RemarksDr. Paul Beck, Division of Gastroenterology,University of Calgary
8:45 – 9:30 am Keynote: Translational Pediatric IBD ResearchDr. Aleixo Muise, Division of Gastroenterology,Hospital for Sick Children
Learning Objectives:
l Explain what VEOIBD isl Explain the clinical differences in VEOIBD and IBDl Identify patients with IL10R mutationsl Describe the mono genetics and complex genetics associated
with VEOIBD
9:30 – 9:45 am Analysis of the Gut Bacteriome Using 16S andMetagenomics Approaches: Advantages and PitfallsDr. Juan Jovel, University of Alberta
9:45 – 10:00 am Protecting the Gut Against Clostridium Difficile Injury:A Role for Keratinocyte Growth FactorDr. Basmah Alhassan, University of Calgary
10:00 – 10:30 am Break & Poster Viewing
10:30 – 10:45 am Gastroenterologist Performed Point of Care Ultrasoundis Accurate in Detection of Crohn’s Disease ActivityDr. Cathy Lu, University of Alberta
10:45 – 11:00 am Expression and Function of Antimicrobial β-defensins isInnately Regulated by MUC2 MucinDr. Eduardo Cobo, University of Calgary
6
7
11:00 – 11:15 am Which Patients Should have a Duodenal Bulb Biopsy toDiagnose Celiac Disease?Dr. Dominica Gidrewicz, Alberta Children's Hospital
11:15 – 11:30 am The Need for Repeat Endoscopic RetrogradeCholangiopancreatography in Patients with BiliaryLeaks Following CholecystectomyDr. Apostolos Tsolakis, University of Calgary
11:30 am – 1:00 pm Lunch Lago Restaurant
PosterJudging Alpine Gallery
11:45 am –12:45 pm Lunch Symposium: Mount Temple AManaging the Treatment-Experienced Hepatitis C Patient in a New Era
Lunch sponsored by
Chair: Dr. Robert J. Bailey, Royal Alexandra Hospital,University of Alberta
Learning Objectives:
l Provide highlights of the latest AASLD Guidelines and theirimpact in Canada
l Discuss how new agents may fit into the current treatmentalgorithm
l Review the Relapser (PROMISE) and Prior Null (COSMOS)case studies as they relate to the treatment-experiencedHepatitis C patient
New Hepatitis C Agents: Updated AASLD Guidelines andRevised Treatment AlgorithmsDr. Mark Swain, Division of Gastroenterology,University of Calgary
Guidelines for the Treatment-Experienced PatientDr. Hemant Shah, Francis Family Liver Clinic,Toronto Western Hospital, University of Toronto
11:45 am –12:45 pm Lunch Symposium: Mount Temple B/CExploring the Early Phase of Crohn’s Disease
Lunch sponsored by
There is a growing recognition that the outcome of therapy inCrohn’s disease is enhanced when introduced at earlier stages ofthe disease, before long-term and potentially irreversible damagehas occurred. More recently, data suggests that biologic therapymay not only be more effective with earlier introduction, but thatspecific pathways may be more amenable to therapy at differenttime periods of the disease process.
In this symposium, we will share a comprehensive review of thedata evaluating the outcome of earlier introduction of biologicsand discuss whether a “window of opportunity” may exist fortimely therapeutic intervention in Crohn’s Disease. We will reviewthe current expert opinion on definitions of “early” disease,criteria for identifying the patient at high risk who would benefitfrom early intervention and recommendations for practicalapplication of these data to clinical practice.
Prof. Laurent Peyrin-Biroulet, InternationalOrganization for the Study of Inflammatory BowelDisease, Nancy University Hospital
Dr. Remo Panaccione, Inflammatory Bowel DiseaseClinic, University of Calgary
1:00 – 4:00 pm CONCURRENT SESSIONS
1:00 – 4:00 pm GI / Liver Nurses’ Program – Part 2 Lakeshore / Beehive
1:00 – 1:30 pm IBD, Biologics and PregnancyDr. Yvette Leung, Division of Gastroenterology,University of Calgary
Learning Objectives:
l Explain why gastroenterologists prefer to continue medicaltherapy in pregnant IBD patients
l Review transplacental passage of anti-TNF drugsl Discuss timing of anti-TNF dosing during pregnancy and
postpartum
1:30 – 1:45 pm Emerging Biologic Therapies for IBDMs. Joan Heatherington, Inflammatory Bowel DiseaseGroup, University of Calgary
8
Learning Objectives:
l Post anti- TNF's whats emerging in inflammatory bowel diseasetreatment -Review interpretation of trough and antibody levels
l Discuss positioning of IL12/23 inhibitors and alpha 4 beta 7'sinto clinical care
l Discuss time to dose response and strategies to get you there.
1:45 – 1:55 pm Q&A
1:55 – 2:20 pm Future of Interferon-Free Hep C TreatmentDr. Rob Myers, Liver Unit, Gastrointestinal Research Group,University of Calgary
Learning Objectives:
l Review the efficacy and safety of emerging interferon-free, alloral therapies for hepatitis C
l Discuss the expanding indications for interferon-free hepatitisC therapies
2:20 – 2:40 pm HIV/HCV Co-Infection ManagementMr. Jeff Kapler, Pharmacist, Southern Alberta Clinicfor HIV/AIDS
Learning Objectives:
l Describe of the interplay between the HumanImmunodeficiency Virus and the Hepatitis C Virus
l Explain of the special challenges in the medical treatment ofcoinfected patients
l Familiar with the current strategy for monitoring and treatingcoinfected patients
2:40 – 2:50 pm Q&A
2:50 – 3:05 pm Break
3:05 – 3:35 pm Management of AscitesDr. Guadalupe Garcia-Tsao, Section of Digestive Disease,Yale School of Medicine
3:35 – 3:50 pm Hepatic EncephalopathyMs. Michelle Carbonneau, Cirrhosis Care Centre,Zeidler Ledcor Centre, University of Alberta
Learning Objectives:
l Define hepatic encephalopathy l Describe the diagnostic features and grading systeml Learn common contributing factors and treatmentsl Recognize the impact on patient and family quality of life
3:50 – 4:00 pm Q&A
4:00 – 4:30 pm Break Alpine Gallery
9
1:00 – 4:00 pm Shaffer Awards – Part 2 Mount Temple A
1:00 – 1:45 pm Keynote: Lab and Clinic-Based Investigations intoPortal HypertensionDr. Juan Gonzales-Abraldes, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Describe the pathophysiology of the portal hypertensionsyndrome
l Review the current clinical needs for diagnostic and prognostictests in portal hypertension
l Summarize non-invasive and invasive tools for the investigationof portal hypertension
1:45 – 2:00 pm Metagenomics Directed Detection of African Swine FeverVirus like Sequences in the Stool of IBD and PSC PatientsMr. Mohammad Salman Reza, University of Alberta
2:00 – 2:15 pm Inhibition of Intestinal Epithelial Apoptosis byProteinase-Activated Receptor 2 Involves EGFR-Transactivation and ConcurrentInactivation of BAD and Up-Regulation of MCL-1Mr. Vadim Iablokov, University of Calgary
2:15 – 2:30 pm A Serum IgG4 Level Greater Than 70mg/dL Predictsthe Eventual Requirement for Liver Transplantationin Patients With Primary Sclerosing CholangitisDr. Farhad Peerani, University of Alberta
2:30 – 2:45 pm Break & Poster Viewing
2:45 – 3:00 pm Compositional Diversity of the Bile Microbiome inPBC and PSC PatientsMs. Mandana Rahbari, University of Alberta
3:00 – 3:15 pm Entamoeba Histolytica Induces Caspase-4/11Activation in Inflammasome SignallingDr. Jeanie Quach, University of Calgary
3:15 – 3:30 pm Do MicroRNAs Work in Concert to Modulate OncogeneExpression in Hepatocellular Carcinoma?Dr. Zhen Lin, University of Alberta
3:30 – 3:45 pm The Effect of Antiretroviral Therapy on Liver Disease in aPrimary Biliary Cirrhosis Mouse ModelDr. David Sharon, University of Alberta
10
3:45 – 4:00 pm Unsedated Peroral Thin Scope Endoscopy forScreening of Esophageal Varices in Endoscopy-NaïveChild-Pugh A CirrhoticsDr. Andrew Flynn, University of Calgary
4:00 – 4:30 pm Break & Poster Viewing Alpine Gallery and Heritage Hall
1:00 – 4:00 pm Advanced Therapeutic Mount Temple B/CEndoscopy in Alberta
1:00 – 1:05 pm Introduction By ModeratorsDr. Tara Chalmers-Nixon, Division of Gastroenterology,University of Calgary
Dr. Robert Bailey, Royal Alexandra Hospital,University of Alberta
1:05 – 1:25 pm Endoscopic Management of Pancreatic Pseudocystsand Walled-off NecrosisDr. Chris Teshima, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Demonstrate the endoscopic methods for drainage ofpseudocysts and the debridement of walled-off pancreasnecrosis
l Highlight important literature regarding management ofpancreatic fluid collections
l Make recommendations for the clinical management ofpancreatic pseudocysts and walled-off necrosis
1:25 – 1:45 pm The Endoscopist’s Approach to the Managementof Biliary DiseaseDr. Jonathan Love, Division of Gastroenterology,University of Calgary
1:45 – 2:05 pm SpyglassDr. Gurpal Sandha, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Brief overview of SpyGlass cholangioscopyl Review current clinical indications for SpyGlass cholangioscopyl Discuss cases in the format of video presentations
2:05 – 2:25 pm Double Balloon Endoscopy and Video Capsule EndoscopyDr. Steven Heitman, Division of Gastroenterology,University of Calgary
2:25 – 2:45 pm Break
11
12
2:45 – 3:05 pm Endoscopic Management of Vascular LesionsDr. Sergio Zepeda-Gomez, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Review the classification and most common types of vascularabnormalities of the gastrointestinal (GI) tract
l Describe the different types of vascular lesions of the GI tracton the basis of anatomy and pathophysiology
l Review the different options of endoscopic treatment for thevascular lesions of the GI tract
3:05 – 3:20 pm PolypectomyDr. Rachid Mohamed, Division of Gastroenterology,University of Calgary
Learning Objectives:
l Review important concepts of advanced colonic polypectomy
3:20 – 3:50 pm Endoscopic Management of Post-BariatricSurgery PatientsDr. Greg Lutzak, Royal Alexandra Hospital,University of Alberta
Learning Objectives:
l Review common bariatric complications encountered in theendoscopy suite
l Discuss endoscopic treatment options l Outline evidence of endoscopic therapy
3:50– 4:00 pm Conclusion
4:00 – 4:30 pm Break Alpine Gallery
Alberta Digestive Disease Summit:
4:30 – 4:45 pm Opening Remarks Mount Temple B/C
Dr. Tara Chalmers-Nixon, President, Alberta Societyof Gastroenterology
4:45 – 6:45 pm PLENARY SESSION #1: Mount Temple B/CSTATE-OF-THE-ART UPDATES
ColonCancerCheck Update: Sharpening the Focus onColonoscopy QualityDr. Linda Rabeneck, Prevention and CancerControl, Cancer Care Ontario
Learning Objectives:
l Explain the evolution and development of colonoscopy qualitystandards for Ontario’s ColonCancerCheck program
l Explain the evidence underlying the components of Ontario’scolonoscopy standards
l Describe how colonoscopy standards will be implemented inOntario
Management of VaricesDr. Guadalupe Garcia-Tsao, Section of Digestive Disease,Yale School of Medicine
How to Change the Natural Course of Crohn’s DiseaseProf. Laurent Peyrin-Biroulet, International Organizationfor the Study of Inflammatory Bowel Disease, Nancy University Hospital
6:45 – 7:30 pm Reception Victoria Foyer
7:30 – 10:00 pm Alberta Society of Gastroenterology Night Victoria
Dinner, Shaffer Awards Ceremony and Alberta Society of Gastroenterology Awards
l Distinguished Educator Award l Distinguished Researcher Awardl Sherbaniuk/Hershfield Award for Distinguished Service
13
Saturday, June 7, 2014
7:00 – 8:00 am Breakfast Symposium: Mount Temple ACancer in IBD: #PracticeChangingInformation
Breakfast sponsored by
Chair: Dr. Richard Fedorak, Division ofGastroenterology, University of Alberta
Learning Objectives:
l Discuss the benefits of targeted biopsy with chromoendoscopyversus random biopsies in the surveillance of colon cancer inpatients with ulcerative colitis
l Using evidence-based medicine, review new data on lowvolume preparations and propose protocols to maximize theefficacy, tolerability and safety of bowel preparations
l Define the liabilities of poor colon preparation during coloncancer screening
Have We Been Doing it Wrong all These Years?Endoscopic Surveillance in UC Dr. Brendan Halloran, Division of Gastroenterology,University of Alberta
The Best Colonoscopy Preparation in Canada:Is it in your Endo Suite?Dr. Lawrence Hookey, Division of Gastroenterology,Queen’s University
What Does the CMPA Have to Say About EffectiveColonoscopy Preparation? Dr. Clarence Wong, Division of Gastroenterology,University of Alberta
14
7:00 – 8:00 am Breakfast Symposium: Mount Temple B/CIBD and Therapeutic Drug Monitoring
Breakfast sponsored by
Chair: Dr. Shane Devlin, Division of Gastroenterology,University of Calgary
Considerations for Improved Disease Managementin Ulcerative Colitis Dr. Remo Panaccione, Inflammatory Bowel Disease Clinic,University of Calgary
Learning Objectives:
l Evaluate the evolving goals of therapy in treating UC as aprogressive disease.
l Evaluate the role of standard and novel therapies in achievingthe treatment goals for UC
l Understand the factors predicting a poor prognosis in UCpatients
l Identify the patients that will best benefit from early biologictherapy
Reactive vs. Proactive Therapeutic Drug Monitoringwith Anti-TNF TherapiesDr. Adam Cheifetz, Center for Inflammatory BowelDisease at Beth Israel Deaconess Medical Center,Harvard Medical School
Learning Objectives:
l Review the data regarding the association between clinicaloutcomes and serum drug (anti-TNF) concentration
l Describe the utility of reactive drug concentration andantibody testing
l Learn the potential for proactive drug concentrationmonitoring in clinical practice
15
16
8:15 – 10:15 am PLENARY SESSION #2: Mount Temple B/CCOLORECTAL CANCER UPDATES
The Ontario Colon Cancer Screening ProgramDr. Linda Rabeneck, Cancer Care Ontario
Learning Objectives:
l Describe the burden of colorectal cancer in Canadal Describe the design of Ontario’s ColonCancerCheck program l Describe learn about the performance of the
ColonCancerCheck program and its future directions
FIT UpdateDr. Clarence Wong, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Understand the benefits of Fecal Immunochemical Test (FIT)l Learn how to apply new screening guidelines to an average
risk population
Surgical Outcomes in Colorectal Cancer Dr. Don Buie, Division of Gastroenterology,University of Calgary
Advances in Adjuvant Therapy for Colorectal Cancer Dr. Scot Dowden, Department of Oncology,University of Calgary
Learning Objectives:
l Review the current literature with regards totherapeutic lines in the treatment of mCRC
l Review the most recent data from ASCO 2014l Interpret the results of biomarker analysis of recent
mCRC studiesl Confront recent dogma and incite questions about
current protocols
10:15 – 10:30 am Break
10:30 am – 12:30 pm PLENARY SESSION #3: Mount Temple B/CSTATE-OF-THE-ART UPDATES
Transition to Adult Care for Adolescents withInflammatory Bowel Disease: Physiological andPsychological IssuesDr. Karen Kroeker, Division of Gastroenterology,University of Alberta
Dr. Melanie Marsh-Joyal, Department of Psychiatry,University of Alberta
Learning Objectives:
l Describe the impact transition from pediatrics to adultmedicine has on patients, families, and physicians
l Explain the biopsychosocial factors impacting family dynamicsin IBD during the transition phase
l Explore techniques helping parents and adolescents transition,including limit and boundary setting
Celiac DiseaseDr. Daniel Leffler, The Celiac Centre, Beth Israel Deaconess Medical Centre
Learning Objectives:
l Appreciate how modern understanding of celiac disease as asystemic autoimmune disorder is changing the clinicalspectrum currently seen
l Explain current diagnostic algorithms for celiac diseasediagnosis and in whom evaluation should be considered
l Appreciate how disease manifestations may affect celiacdisease management
Acute PancreatitisDr. Santhi Swaroop Vege, Division of Gastroenterology& Hepatology, Mayo Clinic
12:30 – 1:30 pm Family Lunch Lago Restaurant
Free Afternoon
1:30 – 4:30 pm FELLOWS’ EXAM PREP COURSE Lakeshore / Beehive
6:30 – 11:30 pm FAMILY BBQ AND DANCE Brewster Barn
17
Sunday, June 8, 2014
7:00 – 8:00 am Breakfast Symposium: Mount Temple ACurrent Management of HCV: The Path to IFN Freedom
Breakfast sponsored by
Learning Objectives:
l Describe new emerging treatments for HCVl Describe noninvasive staging of HCVl Review current and emerging treatment options for hepatitis C
therapy using a case-based approachl Discuss the potential impact of future therapies for HCV on
treatment uptake and disease burden
Hepatitis CDr. Kris Kowdley, Liver Centre of Excellence, DigestiveDisease Institute, Virginia Mason Medical Centre
The Current and Future Landscape ofHepatitis C TherapyDr. Rob Myers, Liver Unit, Gastrointestinal ResearchGroup, University of Calgary
7:00 – 8:00 am Breakfast Symposium: Mount Temple B/CSubsequent Entry Biologics in IBD: Past, Present and Future Clinical Considerations
Breakfast sponsored by
Learning Objectives:
l Examine how protein structure can impact functionl Review previous clinical experience with subsequent entry
biologics/biosimilarsl Discuss the clinical considerations of managing an SEB in
your practice
18
What is a Subsequent Entry Biologic (SEB)? Dr. Richard Fedorak, Division of Gastroenterology,University of Alberta
How Sweet It Is: Glycosylation and Its Effect onMonoclonals Prof. Pauline Rudd, National Institute forBioprocessing Research and Training, Dublin
What Can We Learn From the Past? Clinical Experiencewith Non-IBD SEBs Dr. Brian Feagan, Robarts Clinical Trials Inc,University of Western Ontario
SEBs Are Here: Clinical and Safety Data on Remsima inRheumatoid ArthritisDr. Anthony S. Russell, Division of Rheumatology,University of Alberta
8:15 – 10:15 am CONCURRENT SESSIONS
8:15 – 10:15 am Landmark Liver Updates Mount Temple A
8:15 – 8:45 am Role of Iron Overload in NAFLD Dr. Kris Kowdley, Liver Centre of Excellence, DigestiveDisease Institute, Virginia Mason Medical Centre
Learning Objectives:
l Describe the relationship between hepatic iron deposition anddisease severity in NASH
l Describe the possible mechanism of iron-induced toxicity inNAFLD/NASH
l Describe the impact of iron depletion on NASH
8:45 – 9:15 am Novel Approaches for the Treatment of Cirrhosis andPortal Hypertension: StatinsDr. Juan Gonzalez-Abraldes, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Explain the rationale for the use of statins in portalhypertension in cirrhosis
l Review the preclinical data supporting cirrhosis as an indicationfor statins
l Present the most recent clinical data on statins for thetreatment of cirrhosis
19
20
9:15 – 10:15 am Nutrition and Exercise Therapy for CirrhoticsDr. Maitreyi Raman, Division of Gastroenterology,University of Calgary
Dr. Puneeta Tandon, Division of Gastroenterology,University of Alberta
Learning Objectives:
l Discuss the prevalence and consequences of malnutrition inpatients with cirrhosis
l Describe novel methods of nutrition assessment in patientswith cirrhosis
l Discuss nutritional and exercise optimization strategies inpatients with cirrhosis
8:15 – 10:15 am Landmark Luminal Updates Mount Temple B/C
8:15 – 8:45 am Gut Microbiome ImplicationsDr. Jens Walter, Department of Agricultural, Food and Nutritional Science and Department ofBiological Sciences, University of Alberta
8:45 – 9:15 am Eosinophilic Esophagitis in Pediatric andAdult PatientsDr. Chris Waterhouse, Department of Pediatrics,University of Calgary
9:15 – 9:45 am Metabolic Bone Disease in Gastroenterology Dr. Gregory Kline, Section of Endocrinology,University of Calgary
Learning Objectives:
l Describe the pathophysiologic factors underlying metabolicbone disease in persons with chronic GI diseases
l Review the current limitations in clinical and scientificknowledge and the subsequent difficulties that arise inclinical applications
l Review current relevant guidelines in light of othermetabolic bone diseases and devise a pragmatic anddefendable approach to bone disease in GI patients
21
9:45 – 10:15 am Novel Management Strategies forIrritable Bowel SyndromeDr. Christopher Andrews, Calgary Gut MobilityCentre, University of Calgary
Learning Objectives:
l Apply the evidence of the latest clinical trials in themanagement of Irritable Bowel Syndrome (IBS)
l Integrate these new dietary and medical therapies withexisting treatments for IBS in their practice
10:15 – 10:30 am Break
10:30 am – 12:30 pm PLENARY SESSION #4: Mount Temple B/CUPDATES IN THERAPEUTICS
Contrast-Enhanced Ultrasound for IBD and Liver LesionsDr. Stephanie Wilson, University of Calgary
Learning Objectives:
l Describe the benefit of CEUS for quantitative evaluation ofblood flow to the bowel wall, as a reflection of bowel wallinflammation in IBD
l Explain the advantage of CEUS for characterization of focalliver masses related to its real time dynamic nature, highresolution, and superior sensitivity to its contrast agent
Antiplatelets and Anticoagulants:Implications for EndoscopyDr. Dan Sadowski, Royal Alexandra Hospital
Learning Objectives:
l Gain an awareness of the pitfalls of the newer anti plateletand anticoagulant drugs
l Develop a strategy for pre-endoscopy management ofthese agents
l Utilize reversal agents rationally in the setting of GI bleeding
Challenges and Opportunities Facing LiverTransplant in AlbertaDr. Kelly Burak, Division of Gastroenterology,University of Calgary
Learning Objectives:
l Review the changing trends in the indications for liver transplant(LT) and recognize the increasing need for LT in Alberta
l Recognize our decreasing supply of organs after brain death inAlberta and our increased reliance on live and DCD donors
l Overview new strategies in organ allocation and HCV treatmentthat may impact outcomes of LT
Alberta Health Services Sedation Policy and EndoscopyDr. Mike Murphy, Department of Anesthesiology andPain Medicine, University of Alberta
Learning Objectives:
l Present the objectives of the Provincial Policy and Procedureon Procedural Sedation
l Present the Evidence behind the recommendationsl Introduce the concept of 'Titration Sedation'
12:30 – 2:00 pm Family Lunch Lago Restaurant
12:30 – 2:00 pm Alberta Society of Gastroenterology Mount Temple AAnnual General Meeting + Luncheon
2:00 pm Travel Home
22
23
Dr. Christopher AndrewsDr. Christopher Andrews went to McMaster Medical School, thencompleted residencies in Vancouver in internal medicine andCalgary in gastroenterology. This was followed by postgraduatetraining in gastrointestinal motility and clinical healthresearch at the Mayo Clinic, Rochester. He is a consultantgastroenterologist at Foothills Hospital, Associate Professor inthe Division of Gastroenterology at the University of Calgary, and Co-Lead of the Calgary Gut Motility Clinic at the South
Health Campus. Dr. Andrews’ clinical and research interestsfocus on the diagnosis and management of gut motility disorders, includinggastroparesis, intestinal pseudoobstruction, dyspepsia, and irritable bowel syndrome.
Ms. Sharon Appelman-EszczukMs. Sharon Appelman-Eszczuk is Director of Operations withGastrointestinal and Liver Disease Research, Division ofGastroenterology at the University of Alberta in Edmonton. Sheis a Registered Nurse with bachelors of science degree inNursing and is a Certified Clinical Research Associate. Ms.Appelman-Eszczuk has been working full-time in ClinicalResearch for 22 years, both at a primary care and specialized care levels. As Director of Operations, she is responsible for the
management of clinical trials within the Division. She workswith an excellent core team of 11 individuals that makes clinical trials possible /successful for gastroenterology.
Dr. Donald BuieDr. Donald Buie received his MD and completed his residency ingeneral surgery at the University of Alberta. He attended theUniversity of Minnesota in Minneapolis for a research fellowshipfollowed by a clinical fellowship in colorectal surgery. Hereturned to Calgary to set up practice at the University ofCalgary, Foothills Hospital with a special interest in colorectalsurgery. He has been the site chief for general surgery at the Foothills hospital for the past seven years and has just accepted
the role of Facility Chief of Surgery at the Foothills Hospital.Present research interests include rectal cancer outcomes, and diverticular disease.He is a co-Principle Investigator for the recently successful AIHS PRIHS grant on rectal
S P E A K E R S
24
cancer. He was the Chief Examiner for the Royal College in general surgery and is anexaminer for the American Board of Colon and Rectal Surgery and the Royal Collegein colorectal surgery. He is the Program Director for the Colon and Rectal SurgeryProgram in Calgary
Dr. Kelly BurakDr. Kelly Burak was awarded his MSc in epidemiology from theUniversity of Calgary in 2005 for his thesis entitled “Does theMELD score predict mortality before and after livertransplantation at the University of Alberta?” Dr. Burak is anAssociate Professor of Medicine at the University of Calgarywhere he serves as the Director of the Calgary Liver Unit andSouthern Alberta Liver Transplant Clinic. His clinical and research interests include liver transplantation and
hepatocellular carcinoma. He serves as Chair of the DataWorking Group of the Liver Transplant Advisory Committee for Canadian Blood Services.
Ms. Michelle CarbonneauMs. Michelle Carbonneau completed her masters in Advance Practice Nursing witha hepatology focus in 2008 at the University of Alberta. She co-established themultidisciplinary Cirrhosis Care Clinic at the University of Alberta Hospital in 2009,and currently participates in clinical care and research in cirrhotic patients. Beforejoining the clinic, she worked as a pre and post liver transplant coordinator formany years.
Dr. Adam CheifetzDr. Adam Cheifetz is currently the Director of the Center forInflammatory Bowel Disease at Beth Israel Deaconess MedicalCenter and Associate Professor at Harvard Medical School. Hehas been cited in Boston Magazine as one of Boston’s TopDoctors on numerous occasions. In addition to his clinical work,he is involved in multiple research projects relating to IBD andhas published over 75 articles and chapters on the subject. Dr. Cheifetz is an active member of the Crohn's and Colitis
Foundation of America (CCFA) and serves as the current Chairman of the New England chapter medical advisory committee. Dr. Cheifetz isactively involved with teaching and mentoring medical students, residents, and fellowsand is Director of the Harvard Medical School Gastroenterology Clerkship Elective andAssistant Director of the Advanced Fellowship in Inflammatory Bowel Disease at BethIsrael Deaconess Medical Center.
25
Dr. Shane DevlinDr.. Shane Devlin graduated from the University of ManitobaFaculty of Medicine in 1999 before coming to the University ofCalgary to complete his internal medicine residency andgastroenterology fellowship, which he completed in 2004. Hethen went on to complete an advanced clinical and researchfellowship in inflammatory bowel disease at Cedars-SinaiMedical Center in Los Angeles, CA. Since 2006, Dr.Devlin has been part of the Inflammatory Bowel Disease Centre at the
University of Calgary and actively participates in clinical trialsfor various therapeutic agents in IBD. He is also the post-graduate training programdirector for the adult gastroenterology program at the University of Calgary.
Dr. Scot DowdenDr. Scot Dowden is a Clinical Associate Professor for theDepartment of Medical Oncology at the University of Calgary.His clinical practice focuses on the treatment of metastaticgastrointestinal tumors and carcinoma of unknown primary. Heis the Chair of the Southern Alberta Gastrointestinal TumorProgram and an Executive Member of the Alberta ProvincialGastrointestinal Tumor Program. He is extensively involved in Continuing Medical Education at all levels and has received
awards for excellence in teaching. Dr. Dowden is involved inclinical research as both a Principal and Co-Investigator. Dr. Dowden also serves as theDirector of the Medical Oncology Training Program at the University of Calgary and as amentor for residents within the Department of Internal Medicine.
Dr. Brian FeaganDr. Brian Feagan is Director of Robarts Clinical Trials at theRobarts Research Institute and a Professor of Medicine at theUniversity of Western Ontario. Dr. Feagan completed a medicaldegree at the University of Western Ontario. His postdoctoraltraining included residency in the Department of Medicine and aclinical fellowship in the Division of Gastroenterology at theUniversity of Western Ontario and Crohn’s and Colitis Foundation of Canada. Dr. Feagan has authored over 100
articles, book chapters, and monographs and over 200abstracts. He has also given over 700 invited presentations at national andinternational scientific meetings.
26
Dr. Richard FedorakDr. Richard Fedorak is Professor of Medicine in the Division ofGastroenterology at the University of Alberta. He serves asDirector for the Centre of Excellence for GastrointestinalInflammation and Immunity Research and Director of theNorthern Alberta Clinical Trials and Research Centre. He has anactive basic gastrointestinal research laboratory in the area ofmucosal immunology, inflammation, and membrane function and structure. In addition, he leads a large gastrointestinal
disease clinical research group. He has published over 500 peer-reviewed manuscripts and book chapters, produced two patents on colonic-specificdrug delivery, and has lectured around the world.
Dr. Guadalupe Garcia-TsaoDr. Guadalupe Garcia-Tsao has been mainly involved in patient-oriented research in the area of the complications of cirrhosis,specifically varices, variceal hemorrhage, ascites andspontaneous bacterial peritonitis (SBP). She was part of theresearch teams that established the threshold portal pressurelevel for the development of varices, the cutoff ascitespolymorphonuclear cell count in the diagnosis of SBP and that performed the only placebo-controlled studies of non-selective
beta-blockers in the prevention of first variceal hemorrhage andin the prevention of the development of varices (multicenter NIH-sponsored clinicaltrial). More recently, her work has looked at predictors of decompensation and death incirrhosis that have led to new paradigms in the natural history of cirrhosis andstratification of patients with cirrhosis.
Dr. Juan Gonzales-AbraldesDr. Juan Gonzales-Abraldes is an Associate Professor of Medicineat the University of Alberta, and a member of the activemedical staff. He gained his MD in 1995 from the University ofSantiago de Compostela, Spain. He completed hisgastroenterology fellowship training in gastroenterology andhepatology at the Liver Unit, Hospital Clinic, University ofBarcelona. He completed his training with a fellowship in liver hemodynamics at the Hepatic Hemodynamic Laboratory,
Hospital Clinic, University of Barcelona, and a postdoctoralfellowship at Yale University, gaining experience in experimental models of portalhypertension. In 2007,he joined the Faculty of the Liver Unit in Barcelona, where hecontinued his research as well as his clinical work in portal hypertension andcirrhosis. In 2013, Dr. Abraldes joined the Division of Gastroenterology at theUniversity of Alberta.
27
Ms. Melissa HarriottMs. Melissa Harriott completed her masters in Advance Practice Nursing with agastroenterology focus at the University of Alberta. She also completed apostgraduate certificate in colonoscopy from Hull University in 2011. For the pastfour years, she has worked at the University of Alberta Hospital on the GI consultservice; on this service she performs regular endoscopic procedures includinggastroscopy and colonoscopy. She also independently performs colonoscopy as part ofthe SCOPE program. The SCOPE program is the Edmonton zone arm of the AlbertaColorectal Cancer Screening Program. Prior to the completion of her ANP training,she worked as a research coordinator in inflammatory bowel disease for many years.
Ms. Joan HeatheringtonMs. Joan Heatherington has worked in many roles as aregistered nurse. Rural, intensive care, labour and delivery andemergency nursing accounted for most of her career beforetaking on a pilot project with the Foothills Medical Centregastroenterology division. Through this pilot project, Joaninitiated a nurse-led colon cancer screening program, triage andpatient support line. She completed a Masters of Nursing and Nurse Practitioner program returning to the clinic as the second
nurse practitioner in Canada with a clinical interest ininflammatory bowel disease. As the nurse practitioner at the University of Calgary IBDclinic, Joan participates in research, clinical care of individuals living with IBD in thecommunity and those admitted to the Foothills Medical Centre.
Dr. Lawrence HookeyDr. Lawrence Hookey is Associate Professor at Queen's Universityand Medical Director of the Endoscopy Units at Hotel DieuHospital and Kingston General Hospital. He has researchinterests in education and quality in colonoscopy and coloncleansing for colonoscopy.
28
Ms. Colleen JohnstonMs. Colleen Johnston is a registered nurse that has worked inthe outpatient GI clinic at the Foothills hospital for over 12years. For the past two years, her primary focus has been thenurse navigator pathway. Ms. Johnston has extensive experiencein emergency and PADIS.
Mr. Jeff KaplerMr. Jeff Kapler graduated with his BSc in pharmacy in Edmontonin 1988, and has worked in a variety of hospital, clinic andcommunity settings in Alberta and Saudi Arabia since then. Hehas been practicing with the pharmacy team at the SouthernAlberta Clinic (“SAC”) for HIV/AIDS for the past 14 years. SACprovides multidisciplinary ambulatory HIV care to roughly 1600outpatients, as well as consultative services for hospitalized patients. In 2012, Mr. Kapler became part of new
interdisciplinary Hepatitis C coinfection team, with a generalpractitioner, hepatologist, and nurse. In this role, he provides ambulatory casemanagement and followup with HIV patients preparing for and undergoing Hepatitis Ctreatment at the Southern Alberta Clinic. Mr. Kapler’s clinical and teaching practiceand his volunteer activities with HIV Community Link (formerly AIDS Calgary) have beenrecognized locally, provincially and nationally.
Dr. Gregory KlineDr. Gregory Kline is a Clinical Associate Professor at theUniversity of Calgary, as well as the Associate Medical Directorof the Foothills Metabolic Bone Clinic and is currently the ActingChief of the Endocrinology Section for the Calgary Zone ofAlberta Health Services. His clinical and research interestsinclude osteoporosis and endocrine hypertension for which heserves as the site investigator for a multi-national study on adrenal hypertension. He has a particular interest in helping
medical trainees learn the basics of clinical research, havingsupervised 17 different medical residents and fellows in program research projects. For these efforts, he has been recognized by his peers, receiving the Faculty ofMedicine’s award for Clinical Teaching as well as the Faculty’s Clinical Research Awardin 2008. Outside of Calgary, he has a particular interest in training junior physiciansworking in the developing world.
29
Dr. Kris KowdleyDr. Kris Kowdley is the Director of the Liver Center of Excellenceand Director of Research at the Digestive Disease Institute atVirginia Mason Medical Center, a Clinical Research Member ofBenaroya Research Institute at Virginia Mason, and ClinicalProfessor of Medicine at the University of Washington. Dr. Kowdley has presented his research in liver diseases at morethan 125 national and international medical centers and scientific symposia.
Dr. Karen KroekerDr. Karen Kroeker is an Assistant Professor of Medicine at theUniversity of Alberta. Dr. Kroeker is involved in the teaching ofresidents and fellows in gastroenterology and inflammatorybowel disease and is the Director of the IBD Training Program.She is an active participant in the teaching of medical studentsat the University of Alberta. Her research interests includeunderstanding the impact of a pediatric diagnosis of IBD on the psychosocial impact of IBD, adherence to therapy and
therapeutic monitoring in IBD, and the role of vitamin D in thetreatment of IBD. Dr. Kroeker joined the Faculty of Medicine at the University ofAlberta in 2010. She has a large practice of patients with inflammatory bowel disease.
Dr. Daniel LefflerDr. Daniel Leffler has worked with celiac disease for over adecade, with clinical care of patients with celiac disease and inclinical and translational research relating to celiac disease.Over the past five years, he has worked at the Celiac Center atBeth Israel Deaconess Medical Center, currently one of the threelargest celiac centers in the United States. Dr. Leffler’s majorefforts to date have involved the study of factors which influence dietary adherence, non-responsive celiac disease, and
immunologic changes which occur with celiac diseaseactivation. His work thus far has led to the creation of survey tools to assess celiacsymptoms and dietary adherence. He is currently supported by an NIH K23 to continuehis work in celiac disease. Beyond his work in celiac disease, Dr. Leffler is also activelyinvolved in gastroenterology quality assurance and outcomes research including thecost and predictors of post-endoscopy complications and methods of improvingadherence with colorectal cancer surveillance guidelines.
30
Dr. Yvette LeungDr. Yvette Leung is a medical graduate from the University ofCalgary. She completed her gastroenterology fellowship inCalgary, and an advanced IBD fellowship at the University ofChicago. She presently is an Assistant Clinical Professor at theUniversity of Calgary, with research interests in reproductionand IBD, and transition of the pediatric IBD patient. She is co-chair of the Maternofetal Outcomes Canadian Registry.
Dr. Jonathan LoveDr. Jonathan Love is a gastroenterologist and therapeuticendoscopist in Calgary, Alberta. Originally from Ontario, hestudied medicine at Queen's, and after internal medicine inToronto and a GI subspecialty in Edmonton, he did a fellowshipin therapeutic endoscopy in Brussells, Belgium with ProfessorMichel Cremer. He is presently the Medical Director ofEndoscopy for the Calgary Zone and the Head of Therapeutic Endoscopy. Dr. Love is a Clinical Associate Professor of Medicine
at the University of Calgary with an interest in postgraduate medical education in GI endoscopy. In 2013 he was given the Faculty ofMedicine's Continuing Medical Education award for his work in colon upskilling andtraining and is on the national faculty for the Skills Enhancement in EndoscopyProgram that is sponsored by CAG.
Dr. Greg LutzakDr. Greg Lutzak is a member of the Division of Gastroenterology at the RoyalAlexandra Hospital in Edmonton. Dr. Lutzak completed his degree, internalmedicine residency and gastroenterology residency at the University of Alberta.Following completion of his gastroenterology training, he completed a fellowshipin therapeutic endoscopy at Virginia Mason Medical Center in Seattle, Washington.He joined the Royal Alexandra GI group shortly after completing his fellowship. His clinical interests include endoscopic ultrasound (EUS), pancreatico-biliaryendoscopy (ERCP) including cholangioscopy, endoscopic mucosal resection (EMR)and the placement of endoluminal metal stents.
31
Dr. Melanie Marsh-JoyalDr. Melanie Marsh-Joyal is a born and raised Calgarian whocompleted medical school at the University of Calgary in 2004.She then made a bold and unexpected decision to move toEdmonton to pursue residency training in Psychiatry at theUniversity of Alberta. Despite her strong ties to Calgary, sheconverted to Edmontonianism and is now working as anEmergency and Consultation Liaison Psychiatrist at the Royal Alexandra Hospital. To make matters more complicated, she has
recently become an Oilers fan much to her Calgary-basedfamily's chagrin.
Dr. Rachid MohamedDr. Rachid Mohamed is a therapeutic endoscopist in Calgary,based out of the Peter Lougheed Center. Rachid completedmedical school in Edmonton in 2005 and went on to an internalmedicine residency at the University of Alberta. He moved hometo Calgary in 2008 where he completed his gastroenterologygastroenterology fellowship followed by a year in therapeuticendoscopy. Currently, he performs ERCP at the Peter Lougheed Center and endoscopic ultrasound at the Foothills Medical
Center. His interests lie in endoscopy, specifically education andadvanced endoscopic procedures.
Dr. Alexio MuiseDr. Aleixo Muise received his BSc from St. Francis XavierUniversity and then went on to complete a PhD in biochemistryat Dalhousie University. Dr. Muise completed his degree at theUniversity of Toronto and his pediatric residency at the Hospitalfor Sick Children and a subspecialty fellowship in the Division ofGastroenterology, Hepatology and Nutrition. He also completedPost-doctoral training in the laboratory of Dr. Daniela Rotin.
32
Dr. Michael MurphyDr. Michael Murphy is Professor and Chair of the Department ofAnesthesiology and Pain Medicine, University of Alberta and isboard certified in both emergency medicine and anesthesiologyin both the US and Canada. He has served as the Chief ofEmergency Medicine of the Victoria General Hospital and theIzaak Walton Killam Children’s Hospital in Halifax and McMasterUniversity Medical Center in Hamilton. Dr. Murphy served as the first Executive Director of Emergency Medical Services for the
province of Nova Scotia and was responsible for designing andimplementing a high performance, full service, advanced life support EMS system inthe province. He served as the Clinical Chief of Anesthesiology, Lincoln Medical Center,Lincolnton, North Carolina, and as an Emergency Physician at Carolinas Medical Centerin Charlotte, North Carolina. He is a founding Director of the Difficult Airway Courses:Anesthesia, Emergency and EMS.
Dr. Rob MyersDr. Rob Myers is Associate Professor of Medicine and Director ofthe Viral Hepatitis Clinic at the University of Calgary. Hisresearch interests include the noninvasive assessment of liverfibrosis, epidemiologic and health outcomes research in variousliver diseases, and the investigation of novel therapies forautoimmune and viral liver diseases. He has been funded by theCanadian Institutes for Health Research, the Alberta Heritage Foundation for Medical Research, and the Canadian Liver
Foundation. Dr. Myers is actively involved in investigator-initiated and industry-sponsored clinical trials. Dr. Myers is the past Chair of theEducation Committee of the Canadian Association for the Study of the Liver and amember of the National Education Advisory Committee of the CLF. In 2012, Dr. Myerswas awarded a Queen Elizabeth II Diamond Jubilee Medal for his contributions toresearch and patient care in liver disease.
Dr. Kerri NovakDr. Kerri Novak is a gastroenterologist at the Foothills MedicalCenter in Calgary, who is currently the medical lead in qualityassurance and is Co-Chair for the provincial referral pathway forgastroenterology. As the lead for the Division’s central accessand triage (CAT), in collaboration with the Calgary NorthwestPrimary Care Network, she spearheaded the development of amulti-disciplinary nurse-led clinic, which is now being expanded across the city. Academically, her interests in QA focus on
improving and evaluating access to GI care through noveldelivery mechanisms, and evaluation of use clinical decision tools such as admissionorder sets. In addition, she has interest in IBD and use of ultrasound to diagnosed andmonitor disease.
33
Dr. Remo PanaccioneDr. Remo Panaccione is currently an Associate Professor ofMedicine at the University of Calgary and the Director of theInflammatory Bowel Disease Clinic at the University of Calgary.He has lectured across North America on various topics ininflammatory bowel disease and has delivered over 120 lecturesin the last five years. His special interest lies in the fields ofadvanced immunomodulation and biological therapy. He actively participates in clinical trials of new therapeutic agents
in Crohn’s disease and ulcerative colitis. He is presently themedical director for the Crohn’s and Colitis Foundation Calgary Chapter and sits on theMedical Advisory council for the Crohn’s and Colitis Foundation of Canada. His otherinterest is medical education. He has been recognized as a gold star lecturer, smallgroups leader, and clinical preceptor by the University of Calgary Medical School.
Prof. Laurent Peyrin-BirouletProf. Laurent Peyrin-Biroulet is professor of medicine and headof the inflammatory bowel disease unit at the Nancy UniversityHospital in France. Professor Peyrin-Biroulet received a risingstar award in 2008 from the United European GastroenterologyFederation (UEGF). He is a member of several societies,including the the ClinCom committee of European Crohn’s &Colitis Organization (ECCO). He is Vice-President of the French association of IBD patients and Chair of the IBD Committee of
the French Society of Digestive Endoscopy. He is also Chair ofthe Clinical Trials Task Force at IOIBD and a member of the UEGF Scientific Committee.He is a coordinator for the development of the first Disability Index for IBD andproposed the first definition of early Crohn’s disease. He also contributed to the ECCOworkshops on mucosal healing, malignancies, and GI imaging as a responsible for aworking group.
Dr. Linda RabeneckDr. Linda Rabeneck oversees Cancer Care Ontario’s prevention,screening, research and surveillance programs as the Vice-President, Prevention and Cancer Control. Previously, she was aCCO regional vice president and chief of the Odette CancerCentre at Sunnybrook Health Sciences Centre. Dr. Rabeneck isProfessor of Medicine; Professor, Institute of Health Policy,Management and Evaluation; and Professor, Dalla Lana School of Public Health at the University of Toronto. Dr. Rabeneck is also a
Senior Scientist at the Institute for Clinical Evaluative Sciencesin Toronto. Dr. Rabeneck played a leadership role in launching ColonCancerCheck,Canada's first province-wide colorectal cancer screening program. Dr. Rabeneck hasachieved international recognition for her contributions to the science and practice ofcolorectal cancer screening, and is actively engaged in international efforts to improvethe uptake and quality of colorectal cancer screening.
34
Dr. Maitreyi RamanDr. Maitreyi Raman is a Clinical Associate Professor in theDepartment of Medicine, Division of Gastroenterology at theUniversity of Calgary. Dr. Raman is a physician nutritionspecialist and medical director for the Southern Alberta HomeEnteral and Parenteral Nutrition Program. She has clinical andresearch interests in malnutrition in GI populations, inparticular, inflammatory bowel disease and decompensated cirrhosis. Dr. Raman has implemented a multi-disciplinary high
risk malnutrition clinic designed to target malnutritioncirrhotic patients on the pre-liver transplant list, with a view to providing nutritionassessment, and nutrition support to improve nutritional and eventually clinicaloutcomes in this population.
Prof. Pauline RuddProf. Pauline Rudd is an Adjunct Professor of Glycobiology atUniversity College, Dublin. She heads the GlycoSciencesResearch Group at the National Institute for BioProcessingResearch and Training in Ireland (NIBRT). She has many linkswith pharmaceutical companies across the world becauseGlycoScience is a major area of specialised expertise requiredto ensure the safety and efficacy of biotherapeutic drugs, such as monoclonal antibodies for cancer and autoimmune disorders.
She has more than 300 scientific publications and has given over350 lectures and seminars at international meetings. In 2010 she was awarded theJames Gregory Medal and an Agilent Thought Leader award and in 2012 she received aWaters Global Innovation award. Before moving her group to Dublin in 2006, ProfessorRudd was a member of the Glycobiology Institute for 25 years, where she was a SeniorResearch Fellow and a University Reader in Glycobiology at Oxford University.
Dr. Anthony RussellAfter completing an undergraduate degree in Cambridge,United Kingdom, Dr. Anthony Russell did his clinical training atGuy's Hospital and the Hammersmith Hospital in London. Two years of a research fellowship in Dallas followed two yearsof clinical rheumatology at the Canadian Red Cross hospital. He has been faculty in the Division of Rheumatology at theUniversity of Alberta since his arrival in Canada in 1971. Heremains active in clinical practice as well as some research
and teaching.
35
Dr. Dan SadowskiDr. Dan Sadowski is a clinical gastroenterologist at the RoyalAlexandra Hospital, Edmonton. Dr. Sadowski has an interest incolon cancer screening and GI motility. He serves as Site Leadfor the GI Division at the Royal Alexandra Hospital and also asQuality Lead for the Alberta Colorectal Cancer ScreeningProgram. He is the Past President of the Canadian Associationof Gastroenterology.
Dr. Gurpal SandhaDr. Gurpal Sandha is an Associate Professor in the Department ofMedicine and the Director of Endoscopy at the University ofAlberta Hospital. Dr. Sandha joined the University of Alberta asa consultant in gastroenterology in 2002. His area of expertisefocuses on endoscopic oncology utilizing advanced endoscopictechniques to diagnose and treat a variety of gastrointestinalcancers. These techniques include endoscopic ultrasound, pancreatico-biliary endoscopy including SpyGlass
cholangioscopy, endoscopic mucosal resection of large polypsand the placement of endoluminal metal stents; esophageal, enteral, biliary, andcolonic stents.
Dr. Hemant ShahDr. Hemant Shah is an Assistant Professor, Staff Hepatologist andClinic Director at the Francis Family Liver Clinic, TorontoWestern Hospital, University of Toronto. His clinical focus is viralliver disease and he maintains a busy teaching practice. Inaddition to clinical care, Dr. Shah is actively engaged in projectsto develop innovative models of care for viral hepatitis,progress interprofessional collaboration and improve knowledge levels amongst primary care and specialty providers. He also
serves as Program Director of the hepatology fellowship whichtrains three to five clinical and research fellows annually.
Dr. Mark SwainDr. Mark Swain is currently Head of the Calgary Division ofGastroenterology and Hepatology and Hepatologist/Clinician-Scientist at the University of Calgary. He graduated from anMD-MSc in pharmacology combined program at Queen’sUniversity in Kingston, completed his internal medicine trainingat the University of Toronto and his gastroenterology training atMcMaster University in Hamilton. He then undertook additional training in hepatology in the Liver Unit at the National Institutes
of Health in Bethesda, Maryland. Dr. Swain has basic benchresearch programs in two main areas: Mechanisms underlying the development ofaltered brain function, including fatigue, in liver disease; and the innate immuneresponse in the regulation of hepatic inflammation. Dr. Swain’s clinical research isfocused in the areas of viral hepatitis and autoimmune liver disease.
Dr. Puneeta TandonDr. Puneeta Tandon is a Hepatologist and Director of the PortalHypertension Clinic at the University of Alberta Hospital inEdmonton. She completed her core gastroenterology training atthe University of Alberta, followed by a Master’s in clinicalepidemiology. Her subsequent hepatology training was carriedout at Yale University with Dr. Guadalupe Garcia-Tsao and at theHospital Clinic in Barcelona, Spain with Dr. Jaime Bosch. Her clinical practice includes both pre and post transplant liver
patients. Her research centers on body composition, functionalchanges and bacterial infections in patients with cirrhosis.
Dr. Christopher TeshimaDr. Christopher Teshima completed residency training in internalmedicine and then in gastroenterology at the University ofToronto and the University of Alberta, where he also did aresearch fellowship leading to a Masters degree in clinicalepidemiology. He then pursued an advanced endoscopyfellowship at Erasmus MC University Medical Centre inRotterdam, The Netherlands. Dr. Teshima joined the Division of Gastroenterology at the University of Alberta in 2010. His
clinical interests focus on endoscopic ultrasound, small bowelenteroscopy, video capsule endoscopy and therapeutic endoscopy, including enteralstenting, Zenkers diverticulutomy, polypectomy, and endoscopic mucosal resection.In 2013 he became director of the Therapeutic Endoscopy Training Program at theUniversity of Alberta.
36
Dr. Santhi Swaroop VegeDr. Santhi Swaroop Vege has three decades of experience withacute pancreatitis. He has published many original papers,textbook chapters, systematic reviews, practice guidelines andreviewer roles for national and international activities on acutepancreatitis. Dr. Vege developed a mechanism to capture allthese on the first day itself because of his earlier trials on acutepancreatitis. He has conducted preliminary randomized double-blind, placebo-controlled and allocation – blinded trial with
pentoxifylline and placebo.
Dr. Jens WalterDr. Jens Walter is Associate Professor and Campus AlbertaInnovation Program Chair for Nutrition, Microbes andGastrointestinal Health in the Department of Agricultural, Food& Nutritional Science at the University of Alberta. Dr. Walter’sresearch is primarily concerned with the microbial ecology ofthe human and animal gastrointestinal tract and the metabolicand immunological interactions between the microbiome and its host in relation to health. He views the interrelationship of gut
microbes with their host as a symbiosis and is especiallyinterested in the evolutionary processes that have shaped this partnership and thebiological outcomes for both the host and the microbes. He is also interested in howenvironmental factors, such as diet and lifestyle, and historic processes impact themicrobial communities in the gut and what consequences their effects have for thehost.
Ms. Kathleen WasyliwMs. Kathleen Wasyliw joined the Endoscopy department at theRoyal Alexandra Hospital in Edmonton in 2005, completing apilot project for Video Capsule Endoscopy. In 2006, the VideoCapsule Endoscopy program was created and to date over 900video capsule studies have been completed. In the summer of2000 she joined the Bailey Health Clinic and currently workspart time in Hepatitis C and IBD support. She has also been involved as a research coordinator for clinical trials in hepatitis,
IBD and hematology. Her background includes gastroenterology,family medicine, and pediatric ICU.
37
Dr. Christopher WaterhouseDr. Christopher Waterhouse is an Assistant Professor and Paediatric Gastroenterologistin the Department of Paediatrics at Alberta Children's Hospital. His reseach primarilyinvolves the role of the innate immune system in animal models of colitis, particularlywith regard to microbial recognition by pattern recognition receptors.
Dr. Stephanie WilsonDr. Stephanie Wilson runs one of the most advanced and well-known clinical and research facilities for the investigation ofmicrobubble contrast agents for medical imaging in NorthAmerica, recognized for its accomplishments throughout theworld. She is also a recognized expert in the evaluation ofinflammatory bowel disease with sonography. The advancementand choice of ultrasound for imaging of IBD is a major lifetime passion as is the use CEUS for the diagnosis and management of
HCC.Dr. Wilson has been the recipient of many prestigiousteaching awards including the 2011 Jean A Vezina award for Excellence and Innovationin Radiology from the Société canadienne-française de radiologie, the 2012 JosephHolmes Pioneer Award from the AIUM, and in 2012, recipient of the LifetimeAchievement Award from the Society of Radiologists in Ultrasound.
Dr. Clarence WongDr. Clarence Wong is a gastroenterologist and AssociateProfessor with the Division of Gastroenterology at the Universityof Alberta. He is an Attending Staff gastroenterologist at theRoyal Alexandra Hospital and University of Alberta Hospital.With his focus in gastrointestinal oncology, he is also anAttending Physician at the Cross Cancer Institute and a memberof the Alberta Provincial Gastrointestinal Tumour Group. Currently, he is the provincial medical director of the Alberta
Colorectal Cancer Screening Program and the EdmontonEndoscopic Ablation Program. His research interests include clinical and laboratoryinnovations in colon cancer screening and Barrett’s esophagus. Dr. Wong is a Past-President of the Alberta Society of Gastroenterology. He is also the Director ofAcademic Technologies for the Faculty of Medicine, University of Alberta. He hasreceived regional and national teaching awards for excellence in teaching tomedical students.
38
Dr. Sergio Zepeda-GómezDr. Sergio Zepeda-Gómez obtained his medical degree at LaSalle University in Mexico. He completed training in internalmedicine and gastroenterology as well as a year of training intherapeutic endoscopy at the National Institute of MedicalSciences and Nutrition in Mexico City. He joined the Division ofGastroenterology at the University of Alberta in 2011 as anAssistant Professor. His major interests are in the areas of therapeutic endoscopy including gastrointestinal bleeding,
pancreato-biliary endoscopy, balloon-assisted enteroscopy, andendoscopic mucosal resection among others.
39
40
S P O N S O R S
Platinum Sponsors
41
Gold Sponsors
Silver Sponsors
Conference SecretariatBUKSA Strategic Conference ServicesSuite 307, 10328 – 81 Avenue NWEdmonton, AB T6E 1X2Tel.: 780.436.0983 x257Fax: 780.437.5984Email: [email protected] www.buksa.com/adds
Contact